🧐 ProPicks AI October update is out now! See which stocks made the listPick Stocks with AI

Aker Biomarine AS (AKBM)

Oslo
Currency in NOK
Disclaimer
47.50
-0.35(-0.73%)
Closed
AKBM Scorecard
Full Analysis
Net income is expected to grow this year
High dividend Yield
Fair Value
Day's Range
46.6548.95
52 wk Range
36.20109.80
Prev. Close
47.85
Open
48.95
Day's Range
46.65-48.95
52 wk Range
36.2-109.8
Volume
84,284
Average Volume (3m)
100,956
1-Year Change
25%
Book Value / Share
Unlock
Fair Value
Unlock
Fair Value Upside
Unlock
AKBM Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
7.85
Downside
-83.47%
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in oversold territory

Aker Biomarine AS Company Profile

Aker BioMarine AS engages in harvesting krill and supplies krill-derived products worldwide. It operates through two segments, Ingredients and Brands. The Ingredients segment is involved in the offshore harvesting and production, logistical operations, and onshore manufacturing and sales of krill-derived products for nutraceutical, pet food, and aquaculture industries. The Brands segment produces and distributes private label vitamins and supplements to retailers. The company provides Superba, a krill oil; QRILL Aqua, an ingredient for formulated feeds; FloraMarine, a plant-based marine source of DHA omega-3 from algae; and QRILL Pet, a functional marine ingredient for pets. It also offers LYSOVETA, a supplement product for brain health; and Understory, a protein peptides product. In addition, it distributes human health and nutrition products, and natural supplements, as well as provides AION, a circular solution provider that recycles plastic products. The company was founded in 2006 and is headquartered in Lysaker, Norway. Aker BioMarine ASA is a subsidiary of Aker ASA.

Employees
626
Market
Norway

Compare AKBM to Peers and Sector

Metrics to compare
AKBM
Peers
Sector
Relationship
P/E Ratio
−35.5x−0.9x11.7x
PEG Ratio
−0.360.000.03
Price/Book
1.1x0.8x1.5x
Price / LTM Sales
1.2x0.6x0.9x
Upside (Analyst Target)
76.0%547.9%15.8%
Fair Value Upside
Unlock10.0%7.9%Unlock

People Also Watch

148.40
ODF
+2.34%
4.95
NYKD
+9.51%
10.20
ABL
+0.49%
29.950
SEA1
+3.81%

FAQ

What Is the Aker Biomarine AS (AKBM) Stock Price Today?

The Aker Biomarine AS stock price today is 47.50

What Stock Exchange Does Aker Biomarine AS Trade On?

Aker Biomarine AS is listed and trades on the Oslo stock exchange.

What Is the Stock Symbol for Aker Biomarine AS?

The stock symbol for Aker Biomarine AS is "AKBM."

Does Aker Biomarine AS Pay Dividends? What’s The Current Dividend Yield?

The dividend yield is 94.74%.

What Is the Aker Biomarine AS Market Cap?

As of today, Aker Biomarine AS market cap is 4.17B.

What is Aker Biomarine AS Earnings Per Share?

The Aker Biomarine AS EPS is -0.002.

What Is the Next Aker Biomarine AS Earnings Date?

Aker Biomarine AS will release its next earnings report on 01 Nov 2024.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.